The elevated levels of SREBP-1c and ChREBP found in liver tissue analyses from NAFLD patients highlight their role in promoting TG accumulation and disease progression [32,33]. This evidence concerns the gene SREBF1 and metabolic dysfunction-associated steatotic liver disease.